Friday, October 28, 2016

Constipation, Drug Induced Medications


Drugs associated with Constipation, Drug Induced

The following drugs and medications are in some way related to, or used in the treatment of Constipation, Drug Induced. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Hemosiderosis Medications


Definition of Hemosiderosis:

Transfusional hemosiderosis is the accumulation of iron in patients who receive frequent blood transfusions (such as those with thalassemia, sickle cell disease, aplastic anemia or myelodysplastic syndrome).

Drugs associated with Hemosiderosis

The following drugs and medications are in some way related to, or used in the treatment of Hemosiderosis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Oftaler




Oftaler may be available in the countries listed below.


Ingredient matches for Oftaler



Ketotifen

Ketotifen is reported as an ingredient of Oftaler in the following countries:


  • Chile

International Drug Name Search


Thursday, October 27, 2016

Medical gas


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.


Drug List:


Deep Relief




Deep Relief may be available in the countries listed below.


Ingredient matches for Deep Relief



Ibuprofen

Ibuprofen is reported as an ingredient of Deep Relief in the following countries:


  • Croatia (Hrvatska)

Levomenthol

Levomenthol is reported as an ingredient of Deep Relief in the following countries:


  • Croatia (Hrvatska)

International Drug Name Search


Zinoximor




Zinoximor may be available in the countries listed below.


Ingredient matches for Zinoximor



Cefuroxime

Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Zinoximor in the following countries:


  • Oman

International Drug Name Search


Oxeno




Oxeno may be available in the countries listed below.


Ingredient matches for Oxeno



Loxoprofen

Loxoprofen sodium salt (a derivative of Loxoprofen) is reported as an ingredient of Oxeno in the following countries:


  • Argentina

International Drug Name Search


Haemoprotect




Haemoprotect may be available in the countries listed below.


Ingredient matches for Haemoprotect



Ferrous Sulfate

Ferrous Sulfate is reported as an ingredient of Haemoprotect in the following countries:


  • Germany

International Drug Name Search


Sipcar




Sipcar may be available in the countries listed below.


Ingredient matches for Sipcar



Bromazepam

Bromazepam is reported as an ingredient of Sipcar in the following countries:


  • Argentina

International Drug Name Search


Sarpogrelate Hydrochloride




Sarpogrelate Hydrochloride may be available in the countries listed below.


Ingredient matches for Sarpogrelate Hydrochloride



Sarpogrelate

Sarpogrelate Hydrochloride (JAN) is also known as Sarpogrelate (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Solving




Solving may be available in the countries listed below.


Ingredient matches for Solving



Nimesulide

Nimesulide is reported as an ingredient of Solving in the following countries:


  • Italy

International Drug Name Search


Oplat




Oplat may be available in the countries listed below.


Ingredient matches for Oplat



Carboplatin

Carboplatin is reported as an ingredient of Oplat in the following countries:


  • Venezuela

Oxaliplatin

Oxaliplatin is reported as an ingredient of Oplat in the following countries:


  • Colombia

International Drug Name Search


Dideral




Dideral may be available in the countries listed below.


Ingredient matches for Dideral



Propranolol

Propranolol hydrochloride (a derivative of Propranolol) is reported as an ingredient of Dideral in the following countries:


  • Turkey

International Drug Name Search


CD33 monoclonal antibodies


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Monoclonal antibodies used in immunotherapy are produced artificially from a cell clone therefore consist of a single type of immunoglobulin. They are targeted towards specific antigens and bind to the antigens to form a complex. These complexes can be recognized and destroyed by phagocytes or used for other diagnostic purposes.


Natural antibodies are proteins made by the B-lymphocytes in response to antigens. Each B-cell makes only one type of antibody. For therapeutic purposes a significant amount of a particular antibody is needed. These are obtained from a culture that gives a one type of antibody, which are called monoclonal antibodies.


CD33 is an antigen present on granulocyte and macrophage precursors in the bone marrow. It differentiates myelogenous leukemia cells from lymphoid or erythroid leukemias.


CD33 monoclonal antibodies are administered with other chemotherapy agents, such as cytosine arabinoside and idarubicin, to enhance the cytotoxic effects on acute myeloid leukemia (AML) cells.

See also

Medical conditions associated with CD33 monoclonal antibodies:

  • Acute Myeloid Leukemia

Drug List:


Wednesday, October 26, 2016

Dasen




Dasen may be available in the countries listed below.


Ingredient matches for Dasen



Serrapeptase

Serrapeptase is reported as an ingredient of Dasen in the following countries:


  • Japan

International Drug Name Search


Dafalgan Enfant




Dafalgan Enfant may be available in the countries listed below.


Ingredient matches for Dafalgan Enfant



Paracetamol

Paracetamol is reported as an ingredient of Dafalgan Enfant in the following countries:


  • Belgium

International Drug Name Search


Diazemuls




Diazemuls may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Diazemuls
  • Diazemuls (Actavis UK Ltd) (SPC)

Ingredient matches for Diazemuls



Diazepam

Diazepam is reported as an ingredient of Diazemuls in the following countries:


  • Bahrain

  • Canada

  • Egypt

  • Hong Kong

  • Iran

  • Iraq

  • Ireland

  • Italy

  • Jordan

  • Kuwait

  • Lebanon

  • Netherlands

  • Oman

  • Qatar

  • Saudi Arabia

  • Syria

  • United Arab Emirates

  • United Kingdom

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sulfasalazin-Heyl




Sulfasalazin-Heyl may be available in the countries listed below.


Ingredient matches for Sulfasalazin-Heyl



Sulfasalazine

Sulfasalazine is reported as an ingredient of Sulfasalazin-Heyl in the following countries:


  • Germany

  • Malta

International Drug Name Search


Sereupin




Sereupin may be available in the countries listed below.


Ingredient matches for Sereupin



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Sereupin in the following countries:


  • Italy

International Drug Name Search


Nialamide




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06AF02

CAS registry number (Chemical Abstracts Service)

0000051-12-7

Chemical Formula

C16-H18-N4-O2

Molecular Weight

298

Therapeutic Category

Antidepressant: Inhibitor of monoamine oxidase type A (MAO-A)

Chemical Name

4-Pyridinecarboxylic acid, 2-[3-oxo-3-[(phenylmethyl)amino]propyl]hydrazide

Foreign Names

  • Nialamidum (Latin)
  • Nialamid (German)
  • Nialamide (French)
  • Nialamida (Spanish)

Generic Names

  • Nialamide (OS: DCF, DCIT, BAN)
  • P 1133 (IS)
  • Nialamide (PH: NF XIII, BP 1973)

Brand Name

  • Niamid
    Pfizer, Luxembourg

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Diconal




Diconal may be available in the countries listed below.


UK matches:

  • Diconal Tablets (Amdipharm plc) (SPC)

Ingredient matches for Diconal



Cyclizine

Cyclizine hydrochloride (a derivative of Cyclizine) is reported as an ingredient of Diconal in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Naksetol




Naksetol may be available in the countries listed below.


Ingredient matches for Naksetol



Naproxen

Naproxen is reported as an ingredient of Naksetol in the following countries:


  • Serbia

International Drug Name Search


Tuesday, October 25, 2016

Salora




Salora may be available in the countries listed below.


Ingredient matches for Salora



Loratadine

Loratadine is reported as an ingredient of Salora in the following countries:


  • Bangladesh

International Drug Name Search


Osmonds Gold Fleece Sheep Dip




Osmonds Gold Fleece Sheep Dip may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Osmonds Gold Fleece Sheep Dip



Dimpylate

Dimpylate is reported as an ingredient of Osmonds Gold Fleece Sheep Dip in the following countries:


  • United Kingdom

International Drug Name Search


Diltiazem Stada




Diltiazem Stada may be available in the countries listed below.


Ingredient matches for Diltiazem Stada



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diltiazem Stada in the following countries:


  • Germany

  • Spain

International Drug Name Search


Oxaliplatino Mayne




Oxaliplatino Mayne may be available in the countries listed below.


Ingredient matches for Oxaliplatino Mayne



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliplatino Mayne in the following countries:


  • Norway

  • Spain

International Drug Name Search


Monday, October 24, 2016

Dicloreum ASW




Dicloreum ASW may be available in the countries listed below.


Ingredient matches for Dicloreum ASW



Diclofenac

Diclofenac is reported as an ingredient of Dicloreum ASW in the following countries:


  • Tunisia

International Drug Name Search


SPMC Indomethacin




SPMC Indomethacin may be available in the countries listed below.


Ingredient matches for SPMC Indomethacin



Indometacin

Indometacin is reported as an ingredient of SPMC Indomethacin in the following countries:


  • Sri Lanka

International Drug Name Search


Oxybutynin Stada




Oxybutynin Stada may be available in the countries listed below.


Ingredient matches for Oxybutynin Stada



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynin Stada in the following countries:


  • Germany

International Drug Name Search


Wodny Roztwor Fioletu Gencjanowego




Wodny Roztwor Fioletu Gencjanowego may be available in the countries listed below.


Ingredient matches for Wodny Roztwor Fioletu Gencjanowego



Methylrosanilinium Chloride

Methylrosanilinium Chloride is reported as an ingredient of Wodny Roztwor Fioletu Gencjanowego in the following countries:


  • Poland

International Drug Name Search


Omeprazid




Omeprazid may be available in the countries listed below.


Ingredient matches for Omeprazid



Omeprazole

Omeprazole is reported as an ingredient of Omeprazid in the following countries:


  • Bosnia & Herzegowina

  • Serbia

  • Turkey

International Drug Name Search


Voiding Disorders Medications


Topics under Voiding Disorders

  • Interstitial Cystitis (19 drugs)

  • Neurogenic Bladder (0 drugs)

  • Nocturnal Polyuria (0 drugs)

  • Urinary Incontinence (60 drugs in 2 topics)

  • Urinary Tract Obstruction (2 drugs in 2 topics)





Drug List:


Ventricular Tachycardia Medications


Definition of Ventricular Tachycardia: Ventricular tachycardia is a rapid heart beat initiated within the ventricles, characterized by 3 or more consecutive premature ventricular beats.

Drugs associated with Ventricular Tachycardia

The following drugs and medications are in some way related to, or used in the treatment of Ventricular Tachycardia. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Ventricular Tachycardia





Drug List:


Zolfin




Zolfin may be available in the countries listed below.


Ingredient matches for Zolfin



Aceclofenac

Aceclofenac is reported as an ingredient of Zolfin in the following countries:


  • Bangladesh

International Drug Name Search


Ondansétron Zydus




Ondansétron Zydus may be available in the countries listed below.


Ingredient matches for Ondansétron Zydus



Ondansetron

Ondansetron is reported as an ingredient of Ondansétron Zydus in the following countries:


  • France

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondansétron Zydus in the following countries:


  • France

International Drug Name Search


Topical emollients


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Topical emollients are agents that sooth and soften the skin. They work by moisturizing the skin and protecting it from drying. Emollients are fats and oils such as lanolin, emulsifying ointment and liquid paraffin.


Topical emollients are applied to the skin to prevent eczema, psoriasis and in other conditions, which may dry out the skin. Regular use of emollients may lessen the need for active drugs like corticosteroids in conditions such as eczema and psoriasis.

See also

Medical conditions associated with topical emollients:

  • Burns, External
  • Dermatitis
  • Dermatological Disorders
  • Diaper Rash
  • Dry Skin
  • Eczema
  • Foot Care
  • Ichthyosis
  • Pityriasis rubra pilaris
  • Pruritus
  • Psoriasis
  • Skin and Structure Infection
  • Sunburn

Drug List:


Doxymono




Doxymono may be available in the countries listed below.


Ingredient matches for Doxymono



Doxycycline

Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxymono in the following countries:


  • Germany

International Drug Name Search


Salsonin




Salsonin may be available in the countries listed below.


Ingredient matches for Salsonin



Salicylic Acid

Salicylic Acid sodium (a derivative of Salicylic Acid) is reported as an ingredient of Salsonin in the following countries:


  • Japan

International Drug Name Search


Viramune




In the US, Viramune (nevirapine systemic) is a member of the drug class NNRTIs and is used to treat HIV Infection.

US matches:

  • Viramune

  • Viramune Suspension

  • Viramune XR Extended-Release Tablets

  • Viramune XR

  • Viramune O/S

UK matches:

  • Viramune 200mg tablets
  • Viramune 50mg/5ml oral Suspension
  • Viramune 200mg Tablets (SPC)
  • Viramune 50mg/5ml oral Suspension (SPC)

Ingredient matches for Viramune



Nevirapine

Nevirapine is reported as an ingredient of Viramune in the following countries:


  • Argentina

  • Australia

  • Austria

  • Bahrain

  • Belgium

  • Brazil

  • Canada

  • Chile

  • Colombia

  • Croatia (Hrvatska)

  • Cyprus

  • Czech Republic

  • Denmark

  • Egypt

  • Ethiopia

  • Finland

  • France

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Indonesia

  • Iraq

  • Ireland

  • Israel

  • Italy

  • Japan

  • Jordan

  • Kenya

  • Kuwait

  • Lebanon

  • Libya

  • Luxembourg

  • Malaysia

  • Mexico

  • Netherlands

  • New Zealand

  • Norway

  • Peru

  • Poland

  • Portugal

  • Qatar

  • Romania

  • Russian Federation

  • Saudi Arabia

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Spain

  • Sudan

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Turkey

  • United Arab Emirates

  • United Kingdom

  • United States

  • Venezuela

  • Yemen

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dardum




Dardum may be available in the countries listed below.


Ingredient matches for Dardum



Cefoperazone

Cefoperazone sodium salt (a derivative of Cefoperazone) is reported as an ingredient of Dardum in the following countries:


  • Georgia

  • Italy

  • Poland

  • Singapore

International Drug Name Search


Des




Des may be available in the countries listed below.


Ingredient matches for Des



Desloratadine

Desloratadine is reported as an ingredient of Des in the following countries:


  • Bangladesh

International Drug Name Search


Sunday, October 23, 2016

Desmopresina Mede




Desmopresina Mede may be available in the countries listed below.


Ingredient matches for Desmopresina Mede



Desmopressin

Desmopressin is reported as an ingredient of Desmopresina Mede in the following countries:


  • Georgia

  • Spain

International Drug Name Search


Neutrogena




Ingredient matches for Neutrogena



Salicylic Acid

Salicylic Acid is reported as an ingredient of Neutrogena in the following countries:


  • Australia

  • Chile

  • United States

International Drug Name Search


Orencyclin F-500




Orencyclin F-500 may be available in the countries listed below.


Ingredient matches for Orencyclin F-500



Tetracycline

Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Orencyclin F-500 in the following countries:


  • Peru

International Drug Name Search


Quiflural




Quiflural may be available in the countries listed below.


Ingredient matches for Quiflural



Ofloxacin

Ofloxacin is reported as an ingredient of Quiflural in the following countries:


  • Mexico

International Drug Name Search


Nefopam




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N02BG06

CAS registry number (Chemical Abstracts Service)

0013669-70-0

Chemical Formula

C17-H19-N-O

Molecular Weight

253

Therapeutic Category

Analgesic and antipyretic

Chemical Name

1H-2,5-Benzoxazocine, 3,4,5,6-tetrahydro-5-methyl-1-phenyl-

Foreign Names

  • Nefopamum (Latin)
  • Nefopam (German)
  • Néfopam (French)
  • Nefopam (Spanish)

Generic Names

  • Nefopam (OS: DCIT, BAN)
  • Néfopam (OS: DCF)
  • Nefopam Hydrochloride (OS: BANM, USAN)
  • Fenazoxine (IS)
  • R 738 (IS)

Brand Names

  • Acupan
    Biocodex, Tunisia; 3M, Bahrain; 3M, Israel; 3M, Kenya; 3M, Zimbabwe; Biocodex, France; Douglas, New Zealand; Meda, Belgium; Meda, United Kingdom; Meda, Ireland; Meda, Luxembourg


  • Dosidol
    Domesco, Vietnam


  • Glosic
    Glomed, Vietnam


  • Nefogesic
    Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Oman; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Yemen


  • Nefopam
    Jelfa, Poland


  • Nisidol
    Zenith Biochemicals, Vietnam


  • Oxadol
    Pharma Riace, Russian Federation


  • Panagesic
    Medochemie, Taiwan

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Heptaminol Richard




Heptaminol Richard may be available in the countries listed below.


Ingredient matches for Heptaminol Richard



Heptaminol

Heptaminol hydrochloride (a derivative of Heptaminol) is reported as an ingredient of Heptaminol Richard in the following countries:


  • France

International Drug Name Search


Neophrine




Neophrine may be available in the countries listed below.


Ingredient matches for Neophrine



Phenylephrine

Phenylephrine is reported as an ingredient of Neophrine in the following countries:


  • Tunisia

International Drug Name Search


Syrex




Syrex may be available in the countries listed below.


Ingredient matches for Syrex



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Syrex in the following countries:


  • Denmark

International Drug Name Search


Saturday, October 22, 2016

Drenol




Drenol may be available in the countries listed below.


Ingredient matches for Drenol



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Drenol in the following countries:


  • Brazil

International Drug Name Search


Sterisol




Sterisol may be available in the countries listed below.


Ingredient matches for Sterisol



Glutaral

Glutaral is reported as an ingredient of Sterisol in the following countries:


  • Japan

International Drug Name Search


Naturalny Beta Karoten




Naturalny Beta Karoten may be available in the countries listed below.


Ingredient matches for Naturalny Beta Karoten



Betacarotene

Betacarotene is reported as an ingredient of Naturalny Beta Karoten in the following countries:


  • Poland

International Drug Name Search


Neubormitin




Neubormitin may be available in the countries listed below.


Ingredient matches for Neubormitin



Glycyrrhizic Acid

Glycyrrhizic Acid dipotssium (a derivative of Glycyrrhizic Acid) is reported as an ingredient of Neubormitin in the following countries:


  • Japan

International Drug Name Search


Nefelid




Nefelid may be available in the countries listed below.


Ingredient matches for Nefelid



Nifedipine

Nifedipine is reported as an ingredient of Nefelid in the following countries:


  • Greece

International Drug Name Search


Friday, October 21, 2016

Ortho Dienoestrol




Ortho Dienoestrol may be available in the countries listed below.


Ingredient matches for Ortho Dienoestrol



Dienestrol

Dienestrol is reported as an ingredient of Ortho Dienoestrol in the following countries:


  • Egypt

  • Lebanon

  • Sudan

  • Syria

  • Yemen

International Drug Name Search


Infection Prophylaxis, Chronic Lymphocytic Leukemia Medications


There are currently no drugs listed for "Infection Prophylaxis, Chronic Lymphocytic Leukemia". See Chronic Lymphocytic Leukemia.





Drug List:


Supatraz




Supatraz may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Supatraz



Amitraz

Amitraz is reported as an ingredient of Supatraz in the following countries:


  • South Africa

International Drug Name Search


Endometritis Medications


Definition of Endometritis: Endometritis is an inflammation and/or irritation of the endometrium (lining of the uterus). (See also pelvic inflammatory disease.)

Drugs associated with Endometritis

The following drugs and medications are in some way related to, or used in the treatment of Endometritis. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Endometritis





Drug List:


Dexametasona Larjan




Dexametasona Larjan may be available in the countries listed below.


Ingredient matches for Dexametasona Larjan



Dexamethasone

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Dexametasona Larjan in the following countries:


  • Argentina

International Drug Name Search


Soonway




Soonway may be available in the countries listed below.


Ingredient matches for Soonway



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Soonway in the following countries:


  • Taiwan

International Drug Name Search


Orasorbil




Orasorbil may be available in the countries listed below.


Ingredient matches for Orasorbil



Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Orasorbil in the following countries:


  • Portugal

International Drug Name Search


Gallbladder Disease Medications


Definition of Gallbladder Disease: Inflammation, infection, stones, or obstruction of the gallbladder.

Drugs associated with Gallbladder Disease

The following drugs and medications are in some way related to, or used in the treatment of Gallbladder Disease. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Topics under Gallbladder Disease

  • Biliary Tract Tumor (0 drugs in 3 topics)

  • Gallbladder Obstruction w/o Calculus (0 drugs)

  • Gallstones (4 drugs in 8 topics)

Learn more about Gallbladder Disease





Drug List:


Oxybutynin Erwo




Oxybutynin Erwo may be available in the countries listed below.


Ingredient matches for Oxybutynin Erwo



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynin Erwo in the following countries:


  • Austria

International Drug Name Search


Ungel




Ungel may be available in the countries listed below.


Ingredient matches for Ungel



Triclocarban

Triclocarban is reported as an ingredient of Ungel in the following countries:


  • Argentina

International Drug Name Search


Thursday, October 20, 2016

Ethrane


Ethrane is a brand name of enflurane, approved by the FDA in the following formulation(s):


ETHRANE (enflurane - liquid; inhalation)



  • Manufacturer: BAXTER HLTHCARE CORP

    Approved Prior to Jan 1, 1982

    Strength(s): 99.9% [RLD][AN]

Has a generic version of Ethrane been approved?


Yes. The following products are equivalent to Ethrane:


enflurane liquid; inhalation



  • Manufacturer: PIRAMAL CRITICAL

    Approval date: July 29, 1994

    Strength(s): 99.9% [AN]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ethrane. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Ethrane.

See also...


    Omeprazol Alpharma




    Omeprazol Alpharma may be available in the countries listed below.


    Ingredient matches for Omeprazol Alpharma



    Omeprazole

    Omeprazole is reported as an ingredient of Omeprazol Alpharma in the following countries:


    • Portugal

    International Drug Name Search


    Alphagan P


    Alphagan P is a brand name of brimonidine ophthalmic, approved by the FDA in the following formulation(s):


    ALPHAGAN P (brimonidine tartrate - solution/drops; ophthalmic)



    • Manufacturer: ALLERGAN

      Approval date: March 16, 2001

      Strength(s): 0.15% [RLD][AT]


    • Manufacturer: ALLERGAN

      Approval date: August 19, 2005

      Strength(s): 0.1% [RLD]

    Has a generic version of Alphagan P been approved?


    A generic version of Alphagan P has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Alphagan P and have been approved by the FDA:


    brimonidine tartrate solution/drops; ophthalmic



    • Manufacturer: ALCON PHARMS LTD

      Approval date: May 22, 2006

      Strength(s): 0.15% [AT]

    Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Alphagan P. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

    See also: About generic drugs.




    Related Patents


    Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




    • Aqueous ophthalmic formulations and methods for preserving same
      Patent 5,424,078
      Issued: June 13, 1995
      Inventor(s): Dziabo; Anthony J. & Ripley; Paul S.
      Assignee(s): Allergan, Inc.
      Stabilized chlorine dioxide is a preservative for ophthalmic formulations. The stabilized chlorine dioxide, when employed as a preservative ophthalmic formulations is preferably present in an amount of from about 0.0002 or about 0.002 to about 0.02 weight/volume percent. The aqueous ophthalmic formulations, in addition to the stabilized chlorine dioxide and the water which functions as a vehicle for the formulations, contains an ophthalmically acceptable tonicity component effective to maintain the osmolality of the formulation at least about 200 mOsmol/kg, and a buffer to maintain the pH of the ophthalmic formulation within an acceptable physiological range. A method for preserving aqueous ophthalmic formulations utilizing stabilized chlorine dioxide is also set forth.
      Patent expiration dates:

      • June 13, 2012
        ✓ 
        Sponsor has requested patent be delisted


      • June 13, 2012
        ✓ 
        Drug product
        ✓ 
        Sponsor has requested patent be delisted


      • December 13, 2012
        ✓ 
        Pediatric exclusivity




    • Compositions containing therapeutically active components having enhanced solubility
      Patent 6,562,873
      Issued: May 13, 2003
      Inventor(s): Orest; Olejnik & Edward D. S.; Kerslake
      Assignee(s): Allergan, Inc.
      Compositions which include therapeutically active components, solubility enhancing components other than cyclodextrins, and oxy-chloro components, wherein the oxy-chloro components are substantially effective as preservatives. In one embodiment, the oxy-chloro components are useful for preserving the therapeutically active components. In one embodiment, the oxy-chloro components include chlorite components. In a useful embodiment, the solubility enhancing components include carboxymethylcellulose.
      Patent expiration dates:

      • July 10, 2021


      • July 10, 2021
        ✓ 
        Drug product


      • January 10, 2022
        ✓ 
        Pediatric exclusivity




    • Compositions containing &agr;-2-adrenergic agonist components
      Patent 6,627,210
      Issued: September 30, 2003
      Inventor(s): Orest; Olejnik & Edward D. S.; Kerslake
      Assignee(s): Allergan, Inc.
      Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
      Patent expiration dates:

      • July 18, 2021
        ✓ 
        Drug product


      • January 18, 2022
        ✓ 
        Pediatric exclusivity




    • Compositions containing alpha-2-adrenergic agonist components
      Patent 6,641,834
      Issued: November 4, 2003
      Inventor(s): Orest; Olejnik & Edward D. S.; Kerslake
      Assignee(s): Allergan Sales, Inc.
      Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
      Patent expiration dates:

      • July 28, 2021
        ✓ 
        Drug product


      • January 28, 2022
        ✓ 
        Pediatric exclusivity




    • Compositions containing alpha-2-adrenergic agonist components
      Patent 6,673,337
      Issued: January 6, 2004
      Inventor(s): Orest; Olejnik & Edward D. S.; Kerslake
      Assignee(s): Allergan, Inc.
      Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
      Patent expiration dates:

      • July 26, 2021
        ✓ 
        Drug product


      • January 26, 2022
        ✓ 
        Pediatric exclusivity



    See also...

    • Alphagan P Consumer Information (Wolters Kluwer)
    • Alphagan P Consumer Information (Cerner Multum)
    • Alphagan P Advanced Consumer Information (Micromedex)
    • Alphagan P AHFS DI Monographs (ASHP)
    • Brimonidine Consumer Information (Wolters Kluwer)
    • Brimonidine ophthalmic Consumer Information (Cerner Multum)
    • Brimonidine Ophthalmic Advanced Consumer Information (Micromedex)
    • Brimonidine Tartrate AHFS DI Monographs (ASHP)

    Dumocycline




    Dumocycline may be available in the countries listed below.


    Ingredient matches for Dumocycline



    Tetracycline

    Tetracycline hydrochloride (a derivative of Tetracycline) is reported as an ingredient of Dumocycline in the following countries:


    • Bahrain

    • Cyprus

    • Egypt

    • Ethiopia

    • Indonesia

    • Iraq

    • Jordan

    • Kuwait

    • Lebanon

    • Libya

    • Qatar

    • Saudi Arabia

    • Sudan

    • United Arab Emirates

    • Yemen

    International Drug Name Search


    Dipeptidyl peptidase 4 inhibitors


    A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

    Dipeptidyl peptidase 4 inhibitors are oral antidiabetes agents that help control blood sugar levels in Type 2 diabetes patients. They inhibit the enzyme dipeptidyl peptidase 4 and regulate the levels of insulin the body produces after a meal. Dipeptidyl peptidase 4 inhibition results in increased activity of incretins, which inhibits glucagon release. This leads to increased insulin secretion, decreased gastric emptying and therefore decreased blood sugar levels.

    See also

    Medical conditions associated with dipeptidyl peptidase 4 inhibitors:

    • Diabetes, Type 2

    Drug List:


    Neophedan




    Neophedan may be available in the countries listed below.


    Ingredient matches for Neophedan



    Tamoxifen

    Tamoxifen is reported as an ingredient of Neophedan in the following countries:


    • South Africa

    International Drug Name Search


    Diclofenac HBF




    Diclofenac HBF may be available in the countries listed below.


    Ingredient matches for Diclofenac HBF



    Diclofenac

    Diclofenac is reported as an ingredient of Diclofenac HBF in the following countries:


    • Czech Republic

    International Drug Name Search


    Desamix Effe




    Desamix Effe may be available in the countries listed below.


    Ingredient matches for Desamix Effe



    Clotrimazole

    Clotrimazole is reported as an ingredient of Desamix Effe in the following countries:


    • Italy

    Dexamethasone

    Dexamethasone is reported as an ingredient of Desamix Effe in the following countries:


    • Italy

    International Drug Name Search


    Wednesday, October 19, 2016

    Ugurol




    Ugurol may be available in the countries listed below.


    Ingredient matches for Ugurol



    Tranexamic Acid

    Tranexamic Acid is reported as an ingredient of Ugurol in the following countries:


    • Italy

    International Drug Name Search


    Sulix




    Sulix may be available in the countries listed below.


    Ingredient matches for Sulix



    Tamsulosin

    Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Sulix in the following countries:


    • Chile

    International Drug Name Search


    Nitroglycerin BMM Pharma




    Nitroglycerin BMM Pharma may be available in the countries listed below.


    Ingredient matches for Nitroglycerin BMM Pharma



    Nitroglycerin

    Nitroglycerin is reported as an ingredient of Nitroglycerin BMM Pharma in the following countries:


    • Sweden

    International Drug Name Search


    Simpli




    Simpli may be available in the countries listed below.


    Ingredient matches for Simpli



    Azithromycin

    Azithromycin is reported as an ingredient of Simpli in the following countries:


    • Bangladesh

    International Drug Name Search


    Noscapine HCl PCH




    Noscapine HCl PCH may be available in the countries listed below.


    Ingredient matches for Noscapine HCl PCH



    Noscapine

    Noscapine hydrochloride (a derivative of Noscapine) is reported as an ingredient of Noscapine HCl PCH in the following countries:


    • Netherlands

    International Drug Name Search


    Hydroxyzine Hydrochloride




    Hydroxyzine Hydrochloride may be available in the countries listed below.


    Ingredient matches for Hydroxyzine Hydrochloride



    Hydroxyzine

    Hydroxyzine Hydrochloride (BANM) is known as Hydroxyzine in the US.

    International Drug Name Search

    Glossary

    BANMBritish Approved Name (Modified)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    DDC




    DDC may be available in the countries listed below.


    Ingredient matches for DDC



    Zalcitabine

    Zalcitabine is reported as an ingredient of DDC in the following countries:


    • Argentina

    • Peru

    International Drug Name Search


    Tuesday, October 18, 2016

    Newdipine




    Newdipine may be available in the countries listed below.


    Ingredient matches for Newdipine



    Amlodipine

    Amlodipine maleate (a derivative of Amlodipine) is reported as an ingredient of Newdipine in the following countries:


    • Vietnam

    International Drug Name Search


    Streptokinase-Streptodornase




    CAS registry number (Chemical Abstracts Service)

    0008048-16-6

    Therapeutic Categories

    Proteolytic enzyme

    Anticoagulant agent: Fibrinolytic enzyme

    Chemical Name

    Mixture of enzymes obtained from cultures of various strains of Streptococcus haemolyticus

    Foreign Name

    • Streptokinase-Streptodornase (German)

    Brand Names

    • Ernodasa
      Ern, Spain


    • Varidasa
      Cantabria, Spain


    • Varidase
      Meda, Finland; Meda, Norway; Riemser, Austria; Riemser, Germany; Wyeth, Taiwan

    International Drug Name Search


    Vitra




    Vitra may be available in the countries listed below.


    Ingredient matches for Vitra



    Alclometasone

    Alclometasone 17α,21-dipropionate (a derivative of Alclometasone) is reported as an ingredient of Vitra in the following countries:


    • Japan

    International Drug Name Search


    Sutril




    Sutril may be available in the countries listed below.


    Ingredient matches for Sutril



    Torasemide

    Torasemide sodium salt (a derivative of Torasemide) is reported as an ingredient of Sutril in the following countries:


    • Spain

    International Drug Name Search


    Stilbestrol




    Stilbestrol may be available in the countries listed below.


    Ingredient matches for Stilbestrol



    Diethylstilbestrol

    Diethylstilbestrol is reported as an ingredient of Stilbestrol in the following countries:


    • Taiwan

    International Drug Name Search


    Doxil




    In the US, Doxil (doxorubicin liposomal systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Kaposi's Sarcoma, Multiple Myeloma and Ovarian Cancer.

    US matches:

    • Doxil

    Ingredient matches for Doxil



    Doxorubicin

    Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Doxil in the following countries:


    • Israel

    • United States

    Doxycycline

    Doxycycline hydrochloride (a derivative of Doxycycline) is reported as an ingredient of Doxil in the following countries:


    • Dominican Republic

    International Drug Name Search


    Nimutab




    Nimutab may be available in the countries listed below.


    Ingredient matches for Nimutab



    Nimesulide

    Nimesulide is reported as an ingredient of Nimutab in the following countries:


    • India

    International Drug Name Search


    Monday, October 17, 2016

    Wellbutrin Paranova




    Wellbutrin Paranova may be available in the countries listed below.


    Ingredient matches for Wellbutrin Paranova



    Bupropion

    Bupropion hydrochloride (a derivative of Bupropion) is reported as an ingredient of Wellbutrin Paranova in the following countries:


    • Czech Republic

    • Denmark

    International Drug Name Search


    Surgam Leciva




    Surgam Leciva may be available in the countries listed below.


    Ingredient matches for Surgam Leciva



    Tiaprofenic Acid

    Tiaprofenic Acid is reported as an ingredient of Surgam Leciva in the following countries:


    • Slovakia

    International Drug Name Search


    Detensiel




    Detensiel may be available in the countries listed below.


    Ingredient matches for Detensiel



    Bisoprolol

    Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Detensiel in the following countries:


    • France

    International Drug Name Search


    Diltiazem Genericon retard




    Diltiazem Genericon retard may be available in the countries listed below.


    Ingredient matches for Diltiazem Genericon retard



    Diltiazem

    Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Diltiazem Genericon retard in the following countries:


    • Austria

    International Drug Name Search


    UniXan




    UniXan may be available in the countries listed below.


    Ingredient matches for UniXan



    Theophylline

    Theophylline is reported as an ingredient of UniXan in the following countries:


    • Denmark

    International Drug Name Search


    Sunday, October 16, 2016

    Warfarine




    Warfarine may be available in the countries listed below.


    Ingredient matches for Warfarine



    Warfarin

    Warfarine (DCF) is known as Warfarin in the US.

    International Drug Name Search

    Glossary

    DCFDénomination Commune Française

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Miscellaneous antidiabetic agents



    Drug List:


    Zidro




    Zidro may be available in the countries listed below.


    Ingredient matches for Zidro



    Cefadroxil

    Cefadroxil monohydrate (a derivative of Cefadroxil) is reported as an ingredient of Zidro in the following countries:


    • Myanmar

    International Drug Name Search


    Omeprazol dura akut




    Omeprazol dura akut may be available in the countries listed below.


    Ingredient matches for Omeprazol dura akut



    Omeprazole

    Omeprazole is reported as an ingredient of Omeprazol dura akut in the following countries:


    • Germany

    International Drug Name Search


    Verdeso




    In the US, Verdeso (desonide topical) is a member of the drug class topical steroids and is used to treat Atopic Dermatitis, Dermatitis, Eczema and Psoriasis.

    US matches:

    • Verdeso

    • Verdeso Foam

    Ingredient matches for Verdeso



    Desonide

    Desonide is reported as an ingredient of Verdeso in the following countries:


    • United States

    International Drug Name Search


    Soventol HydroSpray




    Soventol HydroSpray may be available in the countries listed below.


    Ingredient matches for Soventol HydroSpray



    Hydrocortisone

    Hydrocortisone is reported as an ingredient of Soventol HydroSpray in the following countries:


    • Germany

    International Drug Name Search


    Clobex


    Clobex is a brand name of clobetasol topical, approved by the FDA in the following formulation(s):


    CLOBEX (clobetasol propionate - lotion; topical)



    • Manufacturer: GALDERMA LABS LP

      Approval date: July 24, 2003

      Strength(s): 0.05% [RLD][AB]

    CLOBEX (clobetasol propionate - shampoo; topical)



    • Manufacturer: GALDERMA LABS

      Approval date: February 5, 2004

      Strength(s): 0.05% [RLD][AB]

    CLOBEX (clobetasol propionate - spray; topical)



    • Manufacturer: GALDERMA LABS LP

      Approval date: October 27, 2005

      Strength(s): 0.05% [RLD][AT]

    Has a generic version of Clobex been approved?


    A generic version of Clobex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Clobex and have been approved by the FDA:


    clobetasol propionate lotion; topical



    • Manufacturer: ACTAVIS MID ATLANTIC

      Approval date: December 4, 2008

      Strength(s): 0.05% [AB]

    clobetasol propionate shampoo; topical



    • Manufacturer: ACTAVIS MID ATLANTIC

      Approval date: June 7, 2011

      Strength(s): 0.05% [AB]

    clobetasol propionate spray; topical



    • Manufacturer: PADDOCK LLC

      Approval date: June 16, 2011

      Strength(s): 0.05% [AT]

    Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Clobex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

    See also: About generic drugs.




    Related Patents


    Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




    • Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
      Patent 5,972,920
      Issued: October 26, 1999
      Inventor(s): Seidel; William E.
      Assignee(s): Dermalogix Partners, Inc.
      One or more formulations for treating psoriasis and other skin disorders characterized by redness, itching, flaking, scaling, and plaque-type growth. The formulation includes a carrier component, one or more active ingredient components, and a surfactant component. The carrier preferably includes an alcohol in substantially equal volume with isopropyl myristate. The active ingredient component preferably includes a superpotent or high-potency corticosteroid such as clobetasol propionate, an anti-flaking ingredient such as zinc pyrithione, or a combination of the two. It may also include an anti-fungal compound. The surfactant component preferably includes an alkyl sulfate such as sodium lauryl sulfate. The formulations made by applied topically either in spray form or as a direct-contact liquid.
      Patent expiration dates:

      • February 12, 2018
        ✓ 
        Drug product




    • Composition and method for treatment of psoriasis
      Patent 5,990,100
      Issued: November 23, 1999
      Inventor(s): Rosenberg; E. William & Glenn; Thomas M. & Skinner, Jr.; Robert B. & Noah; Patricia W.
      Assignee(s): Panda Pharmaceuticals, L.L.C.
      The University of Tennessee Research Corporation
      Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
      Patent expiration dates:

      • March 24, 2018
        ✓ 
        Patent use: TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
        ✓ 
        Drug product




    • Topically applicable O/W emulsions having high glycol content and at least one biologically active agent
      Patent 6,106,848
      Issued: August 22, 2000
      Inventor(s): Preuilh; Isabelle & Willcox; Nathalie
      Assignee(s): Centre International de Recherches Dermatologiques
      Stable, topically applicable oil-in-water bioaffecting emulsions having intermediate viscosity, characteristically ranging from 3 to 10 Pa.multidot.s, comprise (a) from 30% to 50% by weight of at least one pro-penetrating glycol, (b) at least one emulsifying agent, advantageously an anionic amphiphilic polymer, and (c) at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc.
      Patent expiration dates:

      • September 22, 2017




    • Foaming composition for washing and treating hair and/or scalp based on an active principle
      Patent 7,316,810
      Issued: January 8, 2008
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • June 17, 2019
        ✓ 
        Drug product




    • Foaming compositions for hair care
      Patent 7,700,081
      Issued: April 20, 2010
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • January 3, 2022
        ✓ 
        Patent use: TOPICAL TREATMENT OF SCALP PSORIASIS




    • Foaming composition for washing and treating hair and/or scalp based on an active principle
      Patent 8,066,975
      Issued: November 29, 2011
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • June 17, 2019
        ✓ 
        Drug product




    • Foaming compositions for hair care
      Patent 8,066,976
      Issued: November 29, 2011
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • June 17, 2019
        ✓ 
        Drug product



    See also...

    • Clobex Lotion Consumer Information (Wolters Kluwer)
    • Clobex Shampoo Consumer Information (Wolters Kluwer)
    • Clobex Spray Consumer Information (Wolters Kluwer)
    • Clobex Consumer Information (Cerner Multum)
    • Clobex Advanced Consumer Information (Micromedex)
    • Clobetasol Cream Consumer Information (Wolters Kluwer)
    • Clobetasol Emollient Foam Consumer Information (Wolters Kluwer)
    • Clobetasol Foam Consumer Information (Wolters Kluwer)
    • Clobetasol Gel Consumer Information (Wolters Kluwer)
    • Clobetasol Lotion Consumer Information (Wolters Kluwer)
    • Clobetasol Shampoo Consumer Information (Wolters Kluwer)
    • Clobetasol Solution Consumer Information (Wolters Kluwer)
    • Clobetasol Spray Consumer Information (Wolters Kluwer)
    • Clobetasol topical Consumer Information (Cerner Multum)
    • Clobetasol Propionate Advanced Consumer Information (Micromedex)
    • Med Clobetasol Scalp Application Advanced Consumer Information (Micromedex)
    • Ratio-Clobetasol Advanced Consumer Information (Micromedex)
    • Clobetasol Topical application Advanced Consumer Information (Micromedex)
    • Clobetasol Propionate AHFS DI Monographs (ASHP)